TRI-POINT LIQUIMMUNE IMMUONASSAY CONTROL, L-1,2,3

Multi-analyte Controls, All Kinds (assayed)

MEDICAL ANALYSIS SYSTEMS, INC.

The following data is part of a premarket notification filed by Medical Analysis Systems, Inc. with the FDA for Tri-point Liquimmune Immuonassay Control, L-1,2,3.

Pre-market Notification Details

Device IDK931366
510k NumberK931366
Device Name:TRI-POINT LIQUIMMUNE IMMUONASSAY CONTROL, L-1,2,3
ClassificationMulti-analyte Controls, All Kinds (assayed)
Applicant MEDICAL ANALYSIS SYSTEMS, INC. LINCOLN TECHNOLOGY PARK 542 FLYNN RD. Camarillo,  CA  93012
ContactDonna Anderson
CorrespondentDonna Anderson
MEDICAL ANALYSIS SYSTEMS, INC. LINCOLN TECHNOLOGY PARK 542 FLYNN RD. Camarillo,  CA  93012
Product CodeJJY  
CFR Regulation Number862.1660 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1993-03-17
Decision Date1993-07-28

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.